Idoxuridine
Spezifikationen
54-42-2CAS-Nummer
200-207-8EG-Nummer
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dioneIUPAC-Name
C9H11IN2O5Chemische Formel
354.1 g/molMolekulargewicht
idoxuridine; 5-Iodo-2'-deoxyuridine; 54-42-2; 5-Iododeoxyuridine; Idoxuridin; Herplex; Stoxil; 2'-Deoxy-5-iodouridine; Iododeoxyridine; Iodoxuridine; Joddeoxiuridin; IUDR; 5IUDR; IDUR; Iduridin; Idoxene; Kerecid; (+)-5-Iodo-2'-deoxyuridine; Virudox; Dendrid; Iododeoxyuridine; URIDINE, 2'-DEOXY-5-IODO-; Idoxuridina; Idoxuridinum; 5-Iodouracil deoxyriboside; IdUrd; 5-IUDR; Ophthalmadine; Emanil; Idexur; Idulea; Allergan-211; 1-(2-Deoxy-beta-D-ribofuranosyl)-5-iodouracil; NSC-39661; SK&F-14287; DTXSID2045238; SK&F 14287; 1beta-D-2'-Deoxyribofuranosyl-5-iodouracil; 1-beta-D-2'-Deoxyribofuranosyl-5-iodouracil; ALLERGAN211; CHEBI:147675; LGP81V5245; NSC 39661; Uracil, 5-iodo-1-(2-deoxy-beta-D-ribofuranosyl)-; DTXCID0025238; SKF 14287; NSC39661; OftanIDU; 5 Iododeoxyuridine; Oftan IDU; Liquifilm, Herplex; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione; 3H-Labeled Idoxuridine; Idoxuridine, 3H Labeled; 5 Iodo 2' deoxyuridine; 123I-Labeled Idoxuridine; 125I-Labeled Idoxuridine; 131I-Labeled Idoxuridine; Idoxuridine, 123I Labeled; Idoxuridine, 125I Labeled; Idoxuridine, 131I Labeled; 1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-5-iodo-1,2,3,4-tetrahydropyrimidine-2,4-dione; RefChem:55392; D06BB01; J05AB02; S01AD01; 200-207-8; Allergan 211; Allergan 201; Idossuridina [DCIT]; IDU; C9H11IN2O5; 5IdU; MFCD00134656; 1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-iodopyrimidine-2,4(1H,3H)-dione; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione; Antizona; Heratil; 5-Iodo-deoxyuridine; ID2; Iduoculos; 5-Iodo-2 inverted exclamation marka-deoxyuridine; Idoxuridinum [INN-Latin]; Idoxuridina [INN-Spanish]; Idossuridina; 5-Iododesoxyuridine; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-iodo-pyrimidine-2,4-dione; CCRIS 2827; 1-(2-Deoxy-b-D-ribofuranosyl)-5-iodouracil; 2'-Deoxy-L-5-iodouridine; SR-05000001510; 2'-Deoxy-5-iodo-D-uridine; 5-lodo-2'-Deoxyuridine; EINECS 200-207-8; BRN 0030397; UNII-LGP81V5245; AI3-50861; Idoxuridine CRS; HSDB 7479; CAS-54-42-2; NCGC00016243-01; 162239-35-2; Dendrid (TN); Idoxuridine [USAN:USP:INN:BAN:JAN]; 5-iodo-2'deoxyuridine; Idoxuridine 100 microg/mL in Acetonitrile; HERPLEX (TN); IDOXURIDINE [MI]; 5-IdU; Prestwick3_000018; IDOXURIDINE [INN]; IDOXURIDINE [JAN]; IDOXURIDINE [HSDB]; CHEMBL788; Epitope ID:138107; IDOXURIDINE [VANDF]; 5-I-2'-dUrd; SCHEMBL3683; IDOXURIDINE [MART.]; BSPBio_000055; IDOXURIDINE [USP-RS]; IDOXURIDINE [WHO-DD]; IDOXURIDINE [WHO-IP]; 4-24-00-01235 (Beilstein Handbook Reference); MLS002154175; 5-IODO-2-DEOXYURIDINE; BPBio1_000061; orb1224732; orb3032917; SCHEMBL6834964; Idoxuridine (JP18/USP/INN); 2'-Deoxy-5-iodouridine - EP; SCHEMBL10582759; SCHEMBL15850897; 2'-DESOXY-5-IODOURIDINE; IDOXURIDINE [ORANGE BOOK]; GLXC-06574; HMS2090M10; HMS2095C17; HMS2230E10; HMS3712C17; IDOXURIDINE [EP MONOGRAPH]; IDOXURIDINE [USP IMPURITY]; IDOXURIDINE [USP MONOGRAPH]; HY-B0307; IDOXURIDINUM [WHO-IP LATIN]; 5-IUdR, 5-Iodouracil deoxyriboside; Tox21_110324; BDBM50370388; EBC-26704; MSK169312; s1883; AKOS015920431; Tox21_110324_1; AC-8219; CCG-220018; DB00249; ND05147; SMP2_000072; 5-lodo-2'-deoxycytidine(5-I-2'-dU); NCGC00179673-01; NCGC00179673-03; NCGC00179673-05; AS-13469; BP-58646; ND172114; SMR001233472; SY015040; DB-009133; 5-Iodo-2'-deoxyuridine, >=99% (HPLC); I0258; I1257; SW198484-2; 1-(2-Deoxy-ss -D-ribofuranosyl)-5-iodouracil; D00342; 5-iodo-2 inverted exclamation mark -Deoxyuridine; F092965; Q409765; SR-05000001510-1; SR-05000001510-3; SR-05000001510-4; BRD-K76634210-001-12-1; BRD-K76634210-001-14-7; Idoxuridine, European Pharmacopoeia (EP) Reference Standard; Idoxuridine, United States Pharmacopeia (USP) Reference StandardSynonyme